Skip to main content
OpenTrials

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

182 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Completed

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

NCT00556634

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Hospital Torrecardenas Almería, Almeria, Spain
  • Hospital Universitario Puerta del Mar Cadiz, Spain
  • Hospital de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Universitario Reina Sofía Córdoba, Cordoba, Spain
View Trial Details
Active, Not Recruiting

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

NCT05729568

Conditions
HIV-1 Infection
Locations
  • Ruane Clinical Research Group, Inc. Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • UC San Diego (UCSD) AntiViral Research Center (AVRC) San Diego, California, United States
  • Optimus Medical Group San Francisco, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

NCT02881320

Conditions
HIV-1 Infection
Locations
  • Children's National Health System Washington D.C., District of Columbia, United States
  • Midway Immunology and Research Center Ft. Pierce, Florida, United States
  • University of Florida Health Gainesville, Florida, United States
  • USF Clinic at Children's Medical Services (study visits and drug storage) Tampa, Florida, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

NCT05052996

Conditions
HIV-1 Infection
Locations
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Ruane Clinical Research Group, Inc Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • Hoag Medical Group - Newport Beach Newport Beach, California, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

NCT04776252

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 0010) Phoenix, Arizona, United States
  • One Community Health ( Site 0045) Sacramento, California, United States
  • Whitman-Walker Institute ( Site 0039) Washington D.C., District of Columbia, United States
  • Georgetown University Medical Center-Clinical Trials Unit Division of Infectious Diseases ( Site 002 Washington D.C., District of Columbia, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

NCT05631093

Conditions
HIV-1 Infection
Locations
  • Kaiser Permanente-Infectious Disease ( Site 3014) Los Angeles, California, United States
  • Palmtree Clinical Research ( Site 3032) Palm Springs, California, United States
  • Zuckerberg San Francisco General Hospital and Trauma Center-UCSF ID Clinical Trials Center ( Site 30 San Francisco, California, United States
  • Georgetown University Medical Center ( Site 3006) Washington D.C., District of Columbia, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

NCT05630755

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 1425) Phoenix, Arizona, United States
  • Pacific Oaks Medical Group ( Site 1400) Beverly Hills, California, United States
  • Ruane Clinical Research Group, Inc ( Site 1414) Los Angeles, California, United States
  • Mills Clinical Research ( Site 1433) Los Angeles, California, United States
View all 49 locations
View Trial Details

Related conditions